Skip to main content

Table 1 Baseline clinical and demographic characteristics

From: Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case–control study

Variable Mycobacterial lung disease (52) Lung Cancer (139)
Age, y, median (range) 67 (4–91) 67 (38–90)
 Male 17 (32.7) 65 (46.8)
 Female 35 (67.3) 74 (53.2)
CCI, Median (IQR) 1 (0–2) 1 (0–2)
Race  
 Non-Hispanic white 42 (80.8) 120 (86.4)
 Asian 4 (7.7) 7 (5.0)
 Hispanic 4 (7.7) 7 (5.0)
 Black 1 (1.9) 5 (3.6)
 Unknown 1 (1.9) 0
Place of birth  
 United States 40 (77.0) 97 (70.0)
 Non-United States 12 (23.0) 42 (30.0)
Symptom status  
 Asymptomatic 31 (59.6) 73 (52.5)
 Symptomatic 21 (40.4) 66 (47.5)
  • Cough 24 (46.2) 72 (51.8)
  • Dyspnea 10 (19.2) 49 (35.3)
  • Hemoptysis 2 (3.8) 13 (9.4)
  • Wheezing 2 (3.8) 8 (5.8)
  • Self-reported fever 3 (5.8) 2 (1.4)
  • Involuntary weight loss 6 (11.5) 11 (7.9)
  • Chest pain 3 (5.8) 0
  • Night sweats 2 (3.8) 1 (0.7)
Indication for imaging  
 Symptom evaluation 21 (40.4) 66 (47.5)
 Cancer surveillance 13 (25.0) 23 (16.5)
 Incidental finding 18 (34.6) 50 (36.0)
Diagnostic procedure  
 Thoracotomy and biopsy 29 (55.0) 51 (37.0)
 Transthoracic lung biopsy 18 (35.0) 53 (38.0)
 Bronchoscopy and transbronchial lung biopsy 5 (10.0) 35 (25.0)
Selected Comorbidities  
 Hypertension 24 (46.2) 65 (46.8)
 COPD 4 (7.7) 32 (23.0)
 Diabetes 4 (7.7) 21 (15.1)
 Connective tissue disorder 2 (3.8) 5 (3.6)
 Asthma 1 (1.9) 9 (6.5)
 Mitral valve prolapse 3 (5.8) 2 (1.4)
  1. Data are presented as No. (%) unless otherwise specified. Abbreviations: CCI Charlson Comorbidity Index, COPD Chronic obstructive pulmonary disease